Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
MedAvail Holdings (MDVL)
NASDAQ:MDVL
MedAvail Holdings (MDVL) Stock Price & Analysis
154 Followers
MDVL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.16 - $47.54
Previous Close$5.69
Volume1.50K
Average Volume (3M)4.79K
Market Cap
$9.18M
Enterprise ValueN/A
Total Cash (Recent Filing)$15.06M
Total Debt (Recent Filing)$1.51M
Price to Earnings (P/E)-0.2
Beta1.09
Next Earnings
Nov 08, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-28.30
Shares Outstanding1,613,911
10 Day Avg. Volume1,583
30 Day Avg. Volume4,793
Standard Deviation0.22
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.44
Price to Sales (P/S)33.02
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MedAvail Holdings News
Press ReleasesMedAvail Reports Second Quarter 2023 Financial Results
Press ReleasesMedAvail Announces 1-for-50 Reverse Stock Split
Press ReleasesMedAvail Reports First Quarter 2023 Financial Results
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDVL FAQ
What was MedAvail Holdings’s price range in the past 12 months?
MedAvail Holdings lowest stock price was $5.16 and its highest was $47.54 in the past 12 months.
What is MedAvail Holdings’s market cap?
Currently, no data Available
When is MedAvail Holdings’s upcoming earnings report date?
MedAvail Holdings’s upcoming earnings report date is Nov 08, 2023 which is in 40 days.
How were MedAvail Holdings’s earnings last quarter?
MedAvail Holdings released its earnings results on Aug 14, 2023. The company reported -$3.06 earnings per share for the quarter, missing the consensus estimate of -$1.5 by -$1.56.
Is MedAvail Holdings overvalued?
According to Wall Street analysts MedAvail Holdings’s price is currently Overvalued.
Does MedAvail Holdings pay dividends?
MedAvail Holdings does not currently pay dividends.
What is MedAvail Holdings’s EPS estimate?
MedAvail Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedAvail Holdings have?
MedAvail Holdings has 1,613,911 shares outstanding.
What happened to MedAvail Holdings’s price movement after its last earnings report?
MedAvail Holdings reported an EPS of -$3.06 in its last earnings report, missing expectations of -$1.5. Following the earnings report the stock price went down -10.259%.
Which hedge fund is a major shareholder of MedAvail Holdings?
Among the largest hedge funds holding MedAvail Holdings’s share is Deerfield Management Company, LP. It holds MedAvail Holdings’s shares valued at 239K.
---
MedAvail Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.45%
12-Months-Change
Fundamentals
Return on Equity
-146.62%
Trailing 12-Months
Asset Growth
-43.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MedAvail Holdings
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
---
Top 5 ETFs holding MDVL
Vanguard Total Stock Market ETF
$155.54K
Up to five ETFs with an Outperform Smart Score that hold MDVL. The ETFs are listed according to market value of MDVL within the ETF
---